VEGFA and neovascular glaucoma: The intravitreal injection of other anti-VEGF agents such as bevacizumab has been found to play a role in iris neo vessel regression and IOP control in cases of neovascular glaucoma (NVG), and potentially affects the success rate of trabeculectomy with MMC administration.